Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-25-039607
Filing Date
2025-04-28
Accepted
2025-04-25 20:52:53
Documents
22
Period of Report
2025-06-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm252386-2_def14a.htm   iXBRL DEF 14A 967679
5 GRAPHIC bc_netloss-4c.jpg GRAPHIC 51319
6 GRAPHIC bc_share-4c.jpg GRAPHIC 56672
7 GRAPHIC lg_leaptherapeu-4c.jpg GRAPHIC 27914
8 GRAPHIC px_24leaptherapypxy1pg01-bw.jpg GRAPHIC 317543
9 GRAPHIC px_24leaptherapypxy1pg02-bw.jpg GRAPHIC 279385
10 GRAPHIC sg_chrismirabelli-bwlr.jpg GRAPHIC 6677
11 GRAPHIC sg_douglaseonsi-bw.jpg GRAPHIC 7338
  Complete submission text file 0001104659-25-039607.txt   3777493

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lptx-20241231.xsd EX-101.SCH 10009
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lptx-20241231_lab.xml EX-101.LAB 43002
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lptx-20241231_pre.xml EX-101.PRE 8699
24 EXTRACTED XBRL INSTANCE DOCUMENT tm252386-2_def14a_htm.xml XML 251675
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37990 | Film No.: 25875743
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)